North America In-vitro Diagnostics Enzymes Market Size & Outlook
North America in-vitro diagnostics enzymes market, 2018-2030 (US$M)
North America in-vitro diagnostics enzymes market highlights
- The North America in-vitro diagnostics enzymes market generated a revenue of USD 908.7 million in 2023.
- The market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, proteases was the largest revenue generating enzyme type in 2023.
- Proteases is the most lucrative enzyme type segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 908.7 million |
| Market revenue in 2030 | USD 1,526.6 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Proteases |
| Fastest growing segment | Proteases |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proteases |
| Key market players worldwide | Biocatalysts Ltd, Merck KGaA, Codexis Inc, Roche Holding AG, Amano Enzyme, Advanced Enzymes, Amicogen, Dyadic International Inc, BBI Solutions, Affymetrix, American Laboratories, Inc. |
Other key industry trends
- In terms of revenue, North America region accounted for 41.7% of the global in-vitro diagnostics enzymes market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 966.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Diagnostics Enzymes Market Scope
In-vitro Diagnostics Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America in-vitro diagnostics enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Proteases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America in-vitro diagnostics enzymes market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.
North America occupied the largest market share in 2019 owing to high demand for IVD enzymes and increasing prevalence of infectious disorders in the region. To combat with the ongoing COVID19 pandemic, FDA has issued emergency use authorizations for in vitro COVID-19 laboratory developed tests.
In addition, most of these emergency use authorizations are enzyme-linked immunosorbent assay and Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based tests for the detection of SARS-CoV-2.
Owing to the high usability of enzymes during RT-PCR, the development of such tests is expected to generate revenue in the North American market. Rise in the number of cancer cases and adoption of enzymes for histopathology of biopsy samples are also factors expected to propel market growth in the region.
Reasons to subscribe to North America in-vitro diagnostics enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America in-vitro diagnostics enzymes market databook
-
Our clientele includes a mix of in-vitro diagnostics enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America in-vitro diagnostics enzymes market, including forecasts for subscribers. This continent databook contains high-level insights into North America in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America in-vitro diagnostics enzymes market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
